IRRIVAGE

K922785 · Autovage · EYF · Oct 16, 1992 · General, Plastic Surgery

Device Facts

Record IDK922785
Device NameIRRIVAGE
ApplicantAutovage
Product CodeEYF · General, Plastic Surgery
Decision DateOct 16, 1992
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.4014
Device ClassClass 1

Device Story

IrriVage is a nonresorbable gauze/sponge intended for external use. It functions as a mechanical aid for wound management or irrigation. The device is used in clinical or home settings by healthcare providers or patients to assist in cleaning or dressing wounds. It provides a physical medium for fluid absorption or application during wound care procedures.

Technological Characteristics

Nonresorbable gauze/sponge; external use; classified under 21 CFR 878.4014 (Product Code EYF).

Regulatory Classification

Identification

A nonresorbable gauze/sponge for external use is a sterile or nonsterile device intended for medical purposes, such as to be placed directly on a patient's wound to absorb exudate. It consists of a strip, piece, or pad made from open woven or nonwoven mesh cotton cellulose or a simple chemical derivative of cellulose. This classification does not include a nonresorbable gauze/sponge for external use that contains added drugs such as antimicrobial agents, added biologics such as growth factors, or is composed of materials derived from animal sources.

Submission Summary (Full Text)

{1} FDA U.S. FOOD & DRUG ADMINISTRATION October 27, 2022 AutoVage® Joseph P. Rudolph, M.D. 1631 Citation Drive Library, Pennsylvania 15129 Re: K922785 Trade/Device Name: IrriVage® Regulation Number: 21 CFR 878.4014 Regulation Name: Nonresorbable Gauze/Sponge For External Use Regulatory Class: Class I Product Code: EYF Dear Joseph P. Rudolph, M.D.: The Food and Drug Administration (FDA) is sending this letter to notify you of an administrative change related to your previous substantial equivalence (SE) determination letter dated October 16, 1992. Specifically, FDA is updating this SE Letter because FDA has better categorized your device technology under regulation number, 878.4014. Please note that the 510(k) submission was not re-reviewed. For questions regarding this letter please contact Julie Morabito, OHT4: Office of Surgical and Infection Control Devices, 240-402-3839, Julie.Morabito@fda.hhs.gov. Sincerely, Julie A. Morabito -S Julie Morabito, Ph.D. Assistant Director for Plastic Surgery Skin and Wound Devices DHT4B: Division of Infection Control and Plastic Reconstructive Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {2} [LOGO] DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service OCT 16 1992 Food and Drug Administration 1390 Piccard Drive Rockville, MD 20850 Joseph P. Rudolph, M.D. AUTOVAGE® 1631 Citation Drive Library, Pennsylvania 15129 Re: K922785 IrriVage® Regulatory Class: I Dated: August 25, 1992 Received: August 28, 1992 Dear Dr. Rudolph: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments. You may, therefore, market the device, subject to the general controls provisions of the Federal Food, Drug, and Cosmetic Act (Act). The general controls provisions of the Act include requirements for registration, listing of devices, good manufacturing practice, and labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval) it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. In addition, the Food and Drug Administration (FDA) may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under the Radiation Control for Health and Safety Act of 1968, or other Federal Laws or Regulations. This letter immediately will allow you to begin marketing your device as described. An FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and permits your device to proceed to the market, but it does not mean that FDA approves your device. Therefore, you may not promote or in any way represent your device or its labeling as being approved by FDA. If you desire specific advice on the labeling for your device, please contact the Division of {3} Page 2 - Joseph P. Rudolph, M.D. Compliance Operations, Device Labeling Compliance Branch (HFZ-326) at (301) 427-1342. Other general information on your responsibilities under the Act, may be obtained from the Division of Small Manufacturers Assistance at their toll free number (800) 638-2041 or at (301) 443-6597. Sincerely yours, Paul R. Beninger, M.D. Paul R. Beninger, M.D. Acting Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health ![img-0.jpeg](img-0.jpeg)
Innolitics
Guidance Recalls

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...